Matching‐adjusted indirect comparison of isatuximab plus carfilzomib and dexamethasone with daratumumab plus lenalidomide and dexamethasone in relapsed multiple myeloma
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5584
Abstract: Lenalidomide‐based regimens are commonly used for early relapse in patients with relapsed and/or refractory multiple myeloma (RRMM) receiving at least one prior line of therapy. In the absence of head‐to‐head comparison, matching‐adjusted indirect comparison (MAIC)… read more here.
Keywords: matching adjusted; indirect comparison; comparison; adjusted indirect ... See more keywords
Assessing the Impact of a Matching Adjusted Indirect Comparison in a Bayesian Network Meta Analysis.
Sign Up to like & getrecommendations! Published in 2019 at "Research synthesis methods"
DOI: 10.1002/jrsm.1372
Abstract: If IPD is available for some or all trials in an NMA, then incorporating this IPD into an NMA is routinely considered to be preferable. However, the situation often arises where a researcher has IPD… read more here.
Keywords: matching adjusted; network; adjusted indirect; indirect comparison ... See more keywords
Comparative effectiveness of delayed-release dimethyl fumarate versus glatiramer acetate in multiple sclerosis patients: results of a matching-adjusted indirect comparison.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of comparative effectiveness research"
DOI: 10.2217/cer-2016-0085
Abstract: AIM Using matching-adjusted indirect comparison, we compared efficacy outcomes in patients with relapsing-remitting multiple sclerosis treated with delayed-release dimethyl fumarate (DMF) or glatiramer acetate (GA). MATERIALS & METHODS An indirect comparison of DMF (patient-level data)… read more here.
Keywords: matching adjusted; adjusted indirect; multiple sclerosis; indirect comparison ... See more keywords